CDKN2A and glioblastoma: Homozygous deletion of CDKN2A/B at the 9p21 chromosome is an early clonal event in tumorigenesis3 that is homogeneously distributed in glioblastoma multiforme (GBM), pancreatic adenocarcinoma, and lung cancer4.